Understanding cachexia in the context of metastatic progression

Nature Reviews Cancer(2020)

引用 107|浏览5
暂无评分
摘要
Tumours reprogram host physiology, metabolism and immune responses during cancer progression. The release of soluble factors, exosomes and metabolites from tumours leads to systemic changes in distant organs, where cancer cells metastasize and grow. These tumour-derived circulating factors also profoundly impact tissues that are rarely inhabited by metastatic cancer cells such as skeletal muscle and adipose tissue. In fact, the majority of patients with metastatic cancer develop a debilitating muscle-wasting syndrome, known as cachexia, that is associated with decreased tolerance to antineoplastic therapy, poor prognosis and accelerated death, with no approved treatments. In this Perspective, we discuss the development of cachexia in the context of metastatic progression. We briefly discuss how circulating factors either directly or indirectly promote cachexia development and examine how signals from the metastatic process can trigger and amplify this process. Finally, we highlight promising therapeutic opportunities for targeting cachexia in the context of metastatic cancers. This Perspective discusses the development of cachexia in the context of cancer progression, providing insight into how circulating factors contribute to this syndrome, and exploring how signals involved in metastasis can potentially amplify cachexia development.
更多
查看译文
关键词
Cancer therapy,Metastasis,Muscle,Biomedicine,general,Cancer Research
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要